The subscription for Senores Pharmaceuticals IPO opened on December 20 and closed on December 24. Senores Pharmaceuticals IPO subscription statusSenores Pharmaceuticals fetched 51.13 times subscriptions on the final day of the share sale.

According to stock market observers, shares of the company are available at a premium of ₹242 in the grey market today

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024. Investors who subscribed to the public offering can check their allotment status on the official websites of BSE,

Investors can check their allotment by visiting the websites of the Bombay Stock Exchange (BSE) or Link Intime India.

The ongoing offers are expected to list at a premium of as much as 80% over the IPO price. Check their latest grey market premiums ahead of listing next week,

Bidding for the initial public offering (IPO) of Senores Pharmaceuticals Limited began on 20 December 2024 and will remain open until 24 December 2024. So, investors have just one day to apply for the Senores Pharmaceuticals IPO as bidding for the public issue ends today at 5:00 PM.

Investors can check their allotment status through multiple platforms such as NSE, BSE and also through the registrar’s website Link Intime. Here is the step-by-step guide to check your allotment status on each website. Create an account by registering with your details or log in if you already have one.

Senores Pharmaceuticals' IPO witnessed an impressive 13.88 times subscription, amassing bids for 11.8 crore shares compared to the 85.3 lakh shares offered. Retail investors subscribed 38.34 times, while non-institutional investors applied 24.

Senores Pharmaceuticals IPO sees high demand; allocation on Dec 26, GMP suggests strong listing. Stay informed!

Learn how to track your share allotments and discover the latest grey market premiums indicating potential listing prices for Ventive Hospitality, Senores Pharmaceuticals, and Carraro India.